LEIDOS FUNDING TO25, OPTION 7 RCT RESPIRATORY VIRUS

Leidos 资助 TO25，选项 7 随机对照呼吸道病毒

• 批准号: 10935435
• 负责人: ETHAN DMITROVSKY
• 金额: $ 1723.74万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-28 至 2028-08-17
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10935435
• 关键词: Biology; Blinded; Cause of Death; Communicable Diseases; Coronavirus; Data; Disease; Emerging Communicable Diseases; Funding; Human; Incidence; Infectious Agent; Medical; Medical Research; Pathogenesis; Patient-Focused Outcomes; Protocols documentation; Publishing; Randomized; Safety; Therapeutic; acute infection; clinical investigation; improved; innovation; pathogen; previous outbreak; respiratory virus

Infectious diseases remain one of the leading causes of death worldwide despite innovations in medical research and the availability of new treatments. Emerging diseases include outbreaks of previously unknown diseases or known diseases where the incidence in humans has significantly increased in the past two decades. Detailed studies on emerging and re-emerging infectious agents to better understand pathogens’ biology and host pathogenesis are mostly lacking. The initial study protocol under this Task Order is to prepare for a rapid coordinated clinical investigation of acute infections of emerging and re-emerging infectious agents.

尽管医学研究有了创新，有了新的治疗方法，传染病仍然是全世界主要的死亡原因之一。新发疾病包括以前未知疾病或已知疾病的暴发，其中人类发病率在过去二十年中显著增加。对新发和再发感染原的详细研究，以更好地了解病原体的生物学和宿主发病机制，大多缺乏。本任务令下的初步研究方案是准备对新出现和再出现的传染性病原体的急性感染进行快速协调的临床调查。